On July 29, 2025, Rein Therapeutics, Inc. entered into a Pre-Paid Advance Agreement allowing them to receive up to $6 million from Yorkville, starting with an initial advance of $1 million. They also formed a Standby Equity Purchase Agreement permitting them to sell shares worth up to $15 million over 36 months.